SCHEMBL4965400

SCHEMBL4965400

C[C@H](O)[C@H](C)C(N)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.57
TP53 P04637 1/20 0.45
SLC1A3 P43003 3/20 0.42
SLC1A2 P43004 3/20 0.42
SLC1A1 P43005 2/20 0.42
USP2 O75604 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39
GABRP O00591 3/20 0.33
GABRD O14764 3/20 0.33
GABRA1 P14867 3/20 0.33
GABRB1 P18505 3/20 0.33
GABRG2 P18507 3/20 0.33
GABRB3 P28472 3/20 0.33
GABRA5 P31644 3/20 0.33
GABRA3 P34903 3/20 0.33
GABRA2 P47869 3/20 0.33
GABRB2 P47870 3/20 0.33
GABRA4 P48169 3/20 0.33
GABRE P78334 3/20 0.33
GABRA6 Q16445 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14420268 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL14420361 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL598013 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL52746 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL13502497 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL52747 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL13502491 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL5516743 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL3574366 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL599279 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103865940-B A kind of ILE '-hydroxylase gene and genetic engineering bacterium and application TIANJIN UNIVERSITY OF SCIENCE & TECHNOLOGY (CN) 2016-05-11 CN disclosed
EP-1874287-A2 COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF OBESITY AND RELATED SYNDROMES Innodia Inc. (CA) 2008-01-09 EP disclosed
WO-2007107008-A1 COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF DISORDERS OF FAT METABOLISM AND OBESITY INNODIA INC. (CA) 2007-09-27 WO disclosed
CN-1955160-A Method for preparing 4-hydroxy-isoleucine from cucurbit seeds CHENGDU BIOLOG I CAS (CN) 2007-05-02 CN disclosed
WO-2006131836-A2 COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF OBESITY AND RELATED SYNDROMES INNODIA INC. (US) 2006-12-14 WO disclosed